Q-omics provides the consensus-scored MIR4324 profile across patient tissues and cancer cell-line models. MIR4324 expression is associated with patient survival in 19 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, MIR4324 is differentially expressed in 8, with the highest sampling consensus in LIHC. Additionally, MIR4324 RNA expression shows 16,135 significant gene co-expression associations, with the highest sampling consensus in DLBC. Together, these results highlight KIRC, LIHC, and DLBC as cancer lineages where MIR4324 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR4324 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR4324 survival associations across molecular data types. MIR4324 RNA expression shows survival associations in the most cancer types (19). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR4324 RNA expression–survival associations across cancer types. High MIR4324 expression shows unfavorable associations in KIRC, LGG, COAD and LIHC, but favorable associations in UVM and HNSC. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .002). Together, the overview and detailed table identify KIRC as the clearest survival context for MIR4324 RNA expression.
This table summarizes MIR4324 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 8. The strongest signals are observed in LIHC for RNA.
This table ranks reproducible tumor–normal expression differences for MIR4324. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR4324 shows lower tumor expression in THCA, KIRC and LUSC and higher tumor expression in LIHC, HNSC and CHOL. The LIHC box plot shows higher MIR4324 RNA expression in tumor versus normal tissue (log2 FC = +0.296, t-test p = .010).
This table shows molecular features associated with MIR4324 in patient tissues and cancer cell lines. In patient samples, MIR4324 shows the broadest associations at the RNA and protein expression levels, with DLBC recurring as the lineage with the largest associated feature set.
